Ostéoporose : ce qui a changé en 2022 [Osteoporosis: what's new in 2022]
Details
State: Public
Version: Final published version
License: CC BY-NC-ND 4.0
Serval ID
serval:BIB_3F0AA8732C68
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Ostéoporose : ce qui a changé en 2022 [Osteoporosis: what's new in 2022]
Journal
Revue medicale suisse
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
18/01/2023
Peer-reviewed
Oui
Volume
19
Number
809-10
Pages
62-65
Language
french
Notes
Publication types: English Abstract ; Journal Article
Publication Status: ppublish
Publication Status: ppublish
Abstract
The year 2022 has seen numerous studies: questioning the usefulness of vitamin D, the effect of osteoporosis treatments on mortality, and the benefit of parathyroidectomy on fractures in primary hyperparathyroidism. The efficacy of romosozumab is diminished by the treatments prescribed before its introduction. Finally, and fortunately, promising new molecules are available in various countries for the treatment of rare bone diseases.
Keywords
Humans, Osteoporosis/drug therapy, Osteoporosis/etiology, Vitamin D/therapeutic use, Fractures, Bone, Bone and Bones, Bone Diseases, Bone Density, Bone Density Conservation Agents/therapeutic use
Pubmed
Create date
31/01/2023 17:39
Last modification date
21/10/2023 7:12